Inclusion Criteria:  Patients aged 19 years old and older Patients eligible for the product treatment (i.e. on-label treatment) according to the newly approved HFrEF and/or CKD label in Korea Provision of signed and dated written informed consent by the patient or legally acceptable representative  Exclusion Criteria:  Participation in any interventional trial during the treatment with the product. Any off-label indications that are not in accordance with the newly approved label in Korea. Any contraindications for the use of the product (as described in the local prescribing information). Prior use of product, as per local MFDS guidance.